Brevan Howard Capital Management’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.68M Sell
231,624
-201,885
-47% -$3.13M 0.03% 465
2026
Q1
$5.86M Buy
433,509
+329,272
+316% +$4.61M 0.05% 204
2025
Q4
$1.3M Sell
104,237
-43,956
-30% -$474K 0.01% 654
2025
Q3
$1.47M Buy
148,193
+77,716
+110% +$756K 0.01% 713
2025
Q2
$629K Buy
+70,477
New +$596K ﹤0.01% 1254
2024
Q4
– Sell
-57,909
Closed -$672K – 1469
2024
Q3
$672K Sell
57,909
-47,172
-45% -$544K ﹤0.01% 599
2024
Q2
$1.12M Buy
105,081
+81,690
+349% +$903K 0.01% 341
2024
Q1
$279K Buy
+23,391
New +$282K ﹤0.01% 683

Other funds holding VTRS

Brevan Howard Capital Management's VTRS Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Viatris (VTRS) stake by 47% in Q2 2026, selling an estimated $3.13M and leaving 231,624 shares worth $3.68M. The position accounts for 0.03% of the portfolio, ranked #465.

Brevan Howard Capital Management first reported a position in VTRS in Q1 2024 and has held it in 8 quarters since. The position peaked at $5.86M in Q1 2026. 1,033 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Brevan Howard Capital Management held 231,624 shares of Viatris worth $3.68M as of Q2 2026.
  • Brevan Howard Capital Management sold 201,885 Viatris shares in Q2 2026, an estimated $3.13M.
  • Viatris made up 0.03% of Brevan Howard Capital Management's portfolio in Q2 2026, its #465 holding.
  • Brevan Howard Capital Management first reported a position in Viatris in Q1 2024 and has held it in 8 quarters since.
  • Brevan Howard Capital Management's Viatris position peaked at $5.86M in Q1 2026.
  • 1,033 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.